These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 12460902

  • 1. Gene therapy for prostate cancer by targeting poly(ADP-ribose) polymerase.
    Trofimova I, Dimtchev A, Jung M, Rosenthal D, Smulson M, Dritschilo A, Soldatenkov V.
    Cancer Res; 2002 Dec 01; 62(23):6879-83. PubMed ID: 12460902
    [Abstract] [Full Text] [Related]

  • 2. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 1999 May 01; 59(9):2136-41. PubMed ID: 10232600
    [Abstract] [Full Text] [Related]

  • 3. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP, Searle PF, Mautner V, James ND.
    Cancer Res; 2000 Jan 15; 60(2):334-41. PubMed ID: 10667585
    [Abstract] [Full Text] [Related]

  • 4. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
    Bigler D, Gulding KM, Dann R, Sheabar FZ, Conaway MR, Theodorescu D.
    Oncogene; 2003 Feb 27; 22(8):1261-72. PubMed ID: 12606954
    [Abstract] [Full Text] [Related]

  • 5. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 6. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
    Suzuki S, Tadakuma T, Asano T, Hayakawa M.
    Cancer Res; 2001 Feb 15; 61(4):1276-9. PubMed ID: 11245419
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.
    Xie X, Zhao X, Liu Y, Zhang J, Matusik RJ, Slawin KM, Spencer DM.
    Cancer Res; 2001 Sep 15; 61(18):6795-804. PubMed ID: 11559553
    [Abstract] [Full Text] [Related]

  • 8. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.
    Lee SE, Jin RJ, Lee SG, Yoon SJ, Park MS, Heo DS, Choi H.
    Anticancer Res; 2000 Sep 15; 20(1A):417-22. PubMed ID: 10769689
    [Abstract] [Full Text] [Related]

  • 9. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
    Soldatenkov VA, Albor A, Patel BK, Dreszer R, Dritschilo A, Notario V.
    Oncogene; 1999 Jul 08; 18(27):3954-62. PubMed ID: 10435618
    [Abstract] [Full Text] [Related]

  • 10. Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.
    McCarthy HO, Coulter JA, Worthington J, Robson T, Hirst DG.
    J Gene Med; 2007 Jun 08; 9(6):511-20. PubMed ID: 17471586
    [Abstract] [Full Text] [Related]

  • 11. Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-alpha and topoisomerase II alpha in prostate cancer.
    Lee CH, Liu M, Sie KL, Lee MS.
    Anticancer Res; 1996 Jun 08; 16(4A):1805-11. PubMed ID: 8712704
    [Abstract] [Full Text] [Related]

  • 12. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen.
    Pang S, Dannull J, Kaboo R, Xie Y, Tso CL, Michel K, deKernion JB, Belldegrun AS.
    Cancer Res; 1997 Feb 01; 57(3):495-9. PubMed ID: 9012480
    [Abstract] [Full Text] [Related]

  • 13. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
    Bauer JA, Thompson TA, Church DR, Ariazi EA, Wilding G.
    Prostate; 2003 May 15; 55(3):159-67. PubMed ID: 12692781
    [Abstract] [Full Text] [Related]

  • 14. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y, McCadden J, Ferrer F, Kruszewski M, Carducci M, Simons J, Rodriguez R.
    Cancer Res; 2002 May 01; 62(9):2576-82. PubMed ID: 11980652
    [Abstract] [Full Text] [Related]

  • 15. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer.
    Gotoh A, Ko SC, Shirakawa T, Cheon J, Kao C, Miyamoto T, Gardner TA, Ho LJ, Cleutjens CB, Trapman J, Graham FL, Chung LW.
    J Urol; 1998 Jul 01; 160(1):220-9. PubMed ID: 9628654
    [Abstract] [Full Text] [Related]

  • 16. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 17. Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.
    Tsui KH, Feng TH, Chung LC, Chao CH, Chang PL, Juang HH.
    Anticancer Res; 2008 May 01; 28(4A):1969-76. PubMed ID: 18649734
    [Abstract] [Full Text] [Related]

  • 18. Human prostate cancer progression models and therapeutic intervention.
    Chung LW, Kao C, Sikes RA, Zhau HE.
    Hinyokika Kiyo; 1997 Nov 01; 43(11):815-20. PubMed ID: 9436028
    [Abstract] [Full Text] [Related]

  • 19. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
    Chang GT, Jhamai M, van Weerden WM, Jenster G, Brinkmann AO.
    Endocr Relat Cancer; 2004 Dec 01; 11(4):815-22. PubMed ID: 15613454
    [Abstract] [Full Text] [Related]

  • 20. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
    Schatten H, Ripple M, Balczon R, Weindruch R, Chakrabarti A, Taylor M, Hueser CN.
    J Cell Biochem; 2000 Jan 01; 76(3):463-77. PubMed ID: 10649443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.